Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boots Pharmaceuticals Inc.

Division of Abbott Laboratories Inc.

Latest From Boots Pharmaceuticals Inc.

Have FDA Studies Changed Rx Drug Advertising?

FDA answers questions on the impact its research projects have had since the first Rx drug TV commercial aired in 1983.

Advertising, Marketing & Sales FDA

TV Drug Advertising Study Targets Those With Limited Or No Internet Use

US FDA will assess value of including 1-800 number and print ad in broadcast commercials; it is among 42 direct-to-consumer studies the agency has undertaken, 13 of which are in progress.

Advertising, Marketing & Sales Regulation

Reddy’s ‘Unfinished Agenda’ Reflects Challenges, Rise of Indian Industry

The late founder of Dr Reddy's Labs, Dr K Anji Reddy was a passionate story teller. Two years after he passed away, his recently released memoirs - An Unfinished Agenda – articulate fascinating glimpses into the challenges faced by the son of a turmeric farmer as he made his way into the daunting world of pharmaceuticals, and into the development of the Indian industry.

BioPharmaceutical Asia Pacific

In Brief: Hi-Tech Pharmacal, OTC firm warned on water tests, John Taylor to leave FDA, NAD and ASA review claims

Hi-Tech Pharmacal profits plummet; FDA warns OTC firm about GMPs; John Taylor to leave FDA; NAD refers claims for Vysera-CLS to FTC; Circulation Patch It claims lack support – ASA; and U.K. liquid OTC recalls.

Consumer Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Carter H Eckert, Pres. & CEO
    James Lyons, VP, Fin.
    Thomas N Thurman, VP, New Products Marketing
    Douglas Reiff, SVP, Marketing & Sales
    Ian Hunneyball, PhD, VP, Research & Development
  • Contact Info
  • Boots Pharmaceuticals Inc.
    Phone: (708) 405-7400
    300 Tri-State Interational Ctr.
    Suite 200
    Lincolnshire, IL 60069-4415
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register